HOME2023-12-11T10:33:05+01:00

Doppel

Established in 1994, Doppel is today recognized as one of Europe’s leading experts in contract R&D and manufacturing. It has start-of-the-art facilities and highest scientific capabilities to service its international pharmaceutical and nutritional clients.

Employees

> 580

People in R&D

> 20

Packs per year

100 mn

Pharma Clients

> 70

News & Highlights

New chapter for Doppel

July 24th, 2024|Highlights, News|

Milan, 23rd July 2024 An agreement was signed today between the international investment fund Trilantic Europe and the Italian investment fund Alto Capital IV, managed by Alto Partners SGR, to [...]

Nasce DMX PHARMA

July 24th, 2024|Highlights, News|

Milano, 23 Luglio 2024 In data odierna è stato siglato un accordo tra il fondo di investimento internazionale Trilantic Europe e il fondo di investimento Italiano Alto Capital IV, gestito [...]

Environmental KPI

OVERALL SCORE

60
60

ENVIRONMENT

60

LABOR & HUMAN RIGHTS

70

ETHICS

60

SUSTAINABLE PROCUREMENT

Corporate history highlights

The company is committed to applying its innovative technologies, deep knowledge and broad experience to develop products of the highest quality for its customers worldwide.

Doppel has a strong track record in building and forging close partnerships with its customers. The company works very closely with its partners to provide high quality services tailored to the specific needs of each individual customer at all stages from formulation, development and manufacturing all the way to marketing and post-marketing controls.

In particular, Doppel provides a specialist consultative service to customers prior to each project in order to determine together the most effective and bespoke solution for the product.